• SGI-1027: From DNMT Inhibition to Cell Death

  2026-09-14

  SGI-1027 is a DNA methyltransferase inhibitor that connects cofactor-site DNMT blockade with tumor suppressor gene reactivation and lysosome-associated cell death. This article translates recent renal cancer findings into a practical framework for designing orthogonal epigenetic and cytotoxicity assays.

• Indazole/Indole Glucagon Receptor Antagonists

  2026-09-13

  The reference study describes a modular indazole- and indole-based series of glucagon receptor antagonists derived from the MK-0893 program. Structure–activity relationship analysis identified compounds with strong in vitro activity, favorable rat pharmacokinetics, and oral efficacy in humanized glucagon receptor mouse models.

• Protein A/G Magnetic Beads: Practical IP Guide

  2026-09-12

  Protein A/G Magnetic Beads (SKU K1305) capture IgG antibodies and antibody-bound complexes from serum, culture supernatant, ascites, and other biological samples for purification, IP, Co-IP, and Ch-IP. They should be used for research workflows involving Fc-region IgG binding, not for diagnostic, clinical, or non-IgG immunoglobulin applications.

• L-Ornithine: From Urea Cycle to Liver–Brain Insight

  2026-09-11

  L-Ornithine is more than a urea cycle intermediate: it is a practical probe for connecting OTC activity, ammonia detoxification, astrocyte metabolism, and liver–brain signaling. This thought-leadership guide translates recent CNS toxicity findings into rigorous assay design and translational strategy.

• Ceruletide for Reliable Pancreatic Cell Assays

  2026-09-11

  Learn how Ceruletide (SKU B8465) can standardize CCK-receptor stimulation in pancreatic injury, viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers peptide handling, assay controls, interpretation, and practical product-selection criteria.

• Protein A/G Magnetic Beads: Practical Workflow Guide

  2026-09-10

  Protein A/G Magnetic Beads provide an Fc-directed method for antibody purification, immunoprecipitation, co-immunoprecipitation, and chromatin immunoprecipitation from complex biological samples. This guide explains setup, controls, and troubleshooting while noting that antibody compatibility, binding capacity, and recovery must be established experimentally because no directly matched paper evidence is available in the supplied materials.

• EdU Imaging Kits for RCC Drug-Response Studies

  2026-09-10

  Use EdU Imaging Kits (HF488) to connect S-phase DNA synthesis with metabolic drug-response mechanisms in renal cell carcinoma. This workflow supports microscopy and flow cytometry, helping distinguish reduced proliferation from nonspecific loss of viability in gingerenone A and sunitinib studies.

• Verbascoside: A Translational PKC/NF-κB Strategy

  2026-09-09

  Verbascoside provides a mechanistically grounded way to interrogate PKC/NF-κB signaling in osteoclastogenesis and inflammatory bone biology. This thought-leadership analysis connects its activity in RANKL-responsive cells with emerging evidence that NF-κB signaling can determine bone tissue resilience, while defining the experimental and translational boundaries that researchers should address before moving toward therapeutic interpretation.

• Microglial Nr4a1, C3, and TMJ-Linked Depression

  2026-09-09

  The reference study links temporomandibular joint inflammation to hippocampal microglial activation, excessive synaptic pruning, and depression-like behaviors through a Nr4a1–C3 mechanism. Its combination of inflammatory modeling, microglial suppression, targeted gene manipulation, and synaptic imaging provides a framework for testing how peripheral pain reshapes central emotional circuits.

• SB525334: TGF-beta1 Receptor Inhibitor Workflow

  2026-09-09

  Build cleaner TGF-beta pathway experiments with SB525334, from rapid Smad2/3 phosphorylation inhibition in cells to fibrosis and renal disease model validation. The workflow also explains how to interpret ALK5 blockade in diabetic wound studies without confusing pathway inhibition with therapeutic benefit.

• GI 254023X: ADAM10 Inhibitor Workflows

  2026-09-08

  GI 254023X combines nanomolar ADAM10 inhibition with strong ADAM17 selectivity, enabling cleaner studies of sheddase-dependent signaling and barrier injury. This practical guide connects target engagement to Jurkat, endothelial, and preclinical vascular assays while emphasizing dose control, orthogonal readouts, and troubleshooting.

• Verbascoside in Neuroimmune Signaling Research

  2026-09-07

  Verbascoside is a PKC/NF-κB inhibitor that offers a mechanistic way to test how inflammatory signaling may influence microglial synaptic pruning. This article translates findings from a TMJ inflammation study into rigorous assay concepts while distinguishing established evidence from promising cross-domain hypotheses.

• Annexin V-FITC/PI Apoptosis Assay Kit Guide

  2026-09-07

  The Annexin V-FITC/PI Apoptosis Assay Kit provides a practical two-marker workflow for separating viable, early apoptotic, and membrane-compromised cell populations. It is suitable for research flow cytometry or fluorescence microscopy, but the staining pattern should not be treated as a standalone diagnosis of apoptosis mechanism or therapeutic response.

• BRD4–RAC1 Co-targeting in Breast Cancer

  2026-09-05

  The reference study identifies combined BRD4 and RAC1 inhibition as a subtype-aware strategy that suppresses breast cancer growth, migration, stem-like properties, and tumorigenesis. Its mechanistic model connects JQ1 and NSC-23766 activity to disruption of the c-MYC–G9a–FTH1 axis and repression of HDAC1, providing a framework for studying epigenetic and Rac1-dependent cooperation.

• Luminescent ATP Detection Assay Kit for UC Research

  2026-09-04

  The Luminescent ATP Detection Assay Kit converts cellular energy status into a sensitive luminescent readout for ulcerative colitis models, including cultured cells and tissue lysates. Its mild lysis workflow supports complementary protein analyses, helping researchers connect ATP depletion with NOX2-driven oxidative stress, mitochondrial injury, and inflammation.

8564 records 1/571 page Next 12345 下5页 Last page